Leading UK Pharmacies trust Deltera
This PGD covers the daily GLP-1 injectable, Liraglutide. Deltera’s digital platform helps pharmacies manage the daily dosing regimen, patient training on injection technique, and long-term weight tracking.
A Fully Digital Clinical Platform
Integrated Bookings and Payments
Secure & Connected Patient Records
Ditch the paperwork with secure digital records. Deltera automatically shares treatment summaries with the patient’s and sends the required notification to their GP instantly.
Training and Eligibility Requirements
To ensure clinical safety and regulatory compliance, all practitioners using this PGD must meet the following professional standards:
- Professional Registration: Must be a registered healthcare professional (e.g., Pharmacist) with a valid GPhC or PSNI registration and personal professional indemnity insurance.
- Clinical Competency: Practitioners must be self-certified as competent in the specific clinical area covered by this PGD and stay up to date with relevant national guidelines (e.g., The Green Book or NICE clinical summaries).
- Mandatory Training: Current certification in Basic Life Support (BLS) and the management of anaphylaxis is required for all injectable services.
- PGD Authorisation: The practitioner must have read and signed the PGD document within the Deltera Clinical Dashboard, with the authorisation counter-signed by the designated organisational lead or Superintendent.
- Premises Standards: Services must be conducted in a private consultation room that meets national standards for patient confidentiality and clinical safety.
Speak to the clinicians behind the platform
We understand the complexities of PGDs and clinical governance in the UK. Schedule a meeting with our team to see how we can help you navigate the changing landscape of community pharmacy.
Access related PGDs
FAQs
Liraglutide is a daily injection. Deltera’s patient portal provides specific advice on daily administration and helps patients stay compliant with their treatment plan.
Yes. As with all weight management services, Deltera automates the GP notification to ensure the patient’s primary care team is kept informed of their BMI and medication.
No, it is usually used as a monotherapy. Deltera’s pre-screening tools check for current medications to prevent contraindications or duplicate therapies.
Deltera’s data export tools allow you to view patient progress. If the 5% weight loss target isn't met by week 16, the system helps you review and halt treatment as per the PGD.
Still have questions?
Our team are here to support you.
Discover Deltera Practice Management
Deltera Practice Management digitalises your private pharmacy services, providing the complete pharmacy software package to offer a full range of Patient Group Directions (PGDs). Gain the oversight and efficiency you need to thrive.
